BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-3836 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-3836\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07490613-3326@assetmemo.bio
DTSTAMP:20261121T005428Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:SHR-3836: Phase 1 readout est. (NCT07490613)
DESCRIPTION:SHR-3836\, phase 1\, Multiple Myeloma.\nStudy: A Phase I Study 
 of SHR-3836 in Patients With Multiple Myeloma\nEstimated primary completio
 n: April 2028. This is a ClinicalTrials.gov estimate\, not a confirmed rea
 dout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/shr-38
 36#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0
 7490613
URL:https://assetmemo.bio/drug/shr-3836#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
